Bile acids and the gut microbiome

Current Opinion in Gastroenterology

Volumn 30, Issue 3, 2014, Pages 332-338

  Ridlon, Jason M ^a   Kang, Dae J ^a   Hylemon, Phillip B ^a   Bajaj, Jasmohan S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

bile acid 7a dehydroxylation; bile salt hydrolase; cirrhosis; microbiome

Indexed keywords

ANTIINFECTIVE AGENT; BILE ACID; BILE SALT; DEOXYCHOLIC ACID; DEOXYCORTICOSTERONE ACETATE; FARNESOID X RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15; POLYPEPTIDE ANTIBIOTIC AGENT; RNA 16S; UNCLASSIFIED DRUG; CHOLESTEROL 7ALPHA MONOOXYGENASE;

ANTIBIOTIC THERAPY; ANTINEOPLASTIC ACTIVITY; BACTERIAL OVERGROWTH; BILE ACID METABOLISM; BILE ACID SYNTHESIS; CHOLESTEROL LIVER LEVEL; COMMUNITY STRUCTURE; CONJUGATE; DIET; DOWN REGULATION; DYSBIOSIS; HEPATIC ENCEPHALOPATHY; HUMAN; HYDROPHILICITY; INFLAMMATION; INTESTINE FLORA; LIVER; LIVER CANCER; LIVER CELL CARCINOMA; MICROBIAL METABOLISM; NONHUMAN; PORTAL VEIN; POSITIVE FEEDBACK; PROMOTER REGION; REGULATORY MECHANISM; REVIEW; SYSTEMATIC REVIEW; CELL TRANSFORMATION; INTESTINE; LIVER TUMOR; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

BILE ACIDS AND SALTS; CELL TRANSFORMATION, NEOPLASTIC; CHOLESTEROL 7-ALPHA-HYDROXYLASE; HUMANS; INTESTINES; LIVER NEOPLASMS; MICROBIOTA;

EID: 84898546855     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0000000000000057     Document Type: Review

References (41)

1. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486:207-214.
2. Donohoe DR, Garge N, Zhang X, et al the microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 2011; 13:517-526.
3. Christl SU, Eisner HD, Dusel G, et al. Antagonistic effects of sulfide and butyrateonproliferationofcolonic mucosa. Dig DisSci 1996; 41:2477-2481.
4. Human Microbiome Project Consortium. A framework for human microbiome research. Nature 2012; 486:215-221.
5. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124:837-848.
6. Kakiyama G, Pandak WM, Gillevet PM, et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol 2013; 58:949-955.
7. Bajaj JS, Ridlon JM, Hylemon PB, et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 2012; 302:G168-G175.
8. Bajaj JS, Hylemon PB, Ridlon JM, et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol 2012; 303:G675-G685.
9. Bajaj JS, Heuman DM, Hylemon PB, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol 2013. [Epub ahead of print]
10. Begley M, Gahan CG, Hill C.The interaction between bacteria and bile. FEMS Microbiol Rev 2005; 29:625-651.
11. Inagaki T, Moschetta A, Lee YK, et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci USA 2006; 103:3920-3925.
12. Islam KB, Fukiya S, Hagio M, et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011; 141: 1773-1781.
13. Ridlon JM, Alves JM, Hylemon PB, Bajaj JS. Cirrhosis, bile acids and gut micro-biota: unraveling a complex relationship. Gut Microbes 2013; 4:382-387.
14. Ridlon JM, Kang D, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006; 47:241-259.
15. Bernstein H, Bernstein C, Payne CM, et al. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 2005; 589:47-65.
16. Hylemon PB, Zhou H, Pandak WM, et al. Bile acids as regulatory molecules. J Lipid Res 2009; 50:1509-1520.
17. Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499:97-101.
18. Doerner KC, Takamine F, LaVoie CP, et al. Assessment of fecal bacteria with bile acid 7 alpha-dehydroxylating activity for the presence of bai-like genes. Appl Environ Microbiol 1997; 63:1185-1188.
19. Sayin SI, Wahlström A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013; 17:225-235.
20. Hu X, Bonde Y, Eggertsen G, Rudling M. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism. J Intern Med 2014; 275:27-38.
21. Sinha J, Chen F, Miloh T, et al. beta-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes. Am J Physiol Gastrointest Liver Physiol 2008; 295:G996-G1003.
22. Sinal CJ, Tohkin M, Miyata M, et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000; 102:731-744.
23. Inagaki T, Choi M, Moschetta A, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005; 2:217-225.
24. Kim I, Ahn SH, Inagaki T, et al. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 2007; 48:2664-2672.
25. Li F, Jiang C, Krausz KW, et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Com munications 2013; 4:. doi: 10.1038/ncomms3384.
26. Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice. Nature 2012; 487:104-108.
27. Laue H, Denger K, Cook AM. Taurine reduction in anaerobic respiration of Bilophila wadsworthia RZATAU. Appl Environ Microbiol 1997; 63:2016-2021.
28. Hardison WG. Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine. Gastroenterology 1978; 75:71-75.
29. Pavlović N, Stankov K, Mikov M. Probiotics-interactions with bile acids and impact on cholesterol metabolism. Appl Biochem Biotechnol 2012; 168: 1880-1895.
30. Marchesini MI, Connolly J, Delpino MV, et al. Brucella abortus choloylglycine hydrolase affects cell envelope composition and host cell internalization. PLoS One 2011; 6:e28480.
31. Mäkivuokko H, Lahtinen SJ, Wacklin P, et al. Association between the ABO blood group and the human intestinal microbiota composition. BMC Microbiol 2012; 12:94-106.
32. Kawamata Y, Fujii R, Hosoya M, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem 2003; 278:9435-9440.
33. Studer E, Zhou X, Zhao R, et al. Conjugated bile acids activate the sphingo-sine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology 2012; 55:267-276.
34. Sheikh Abdul Kadir SH, Miragoli M, Abu-Hayyeh S, et al. Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardio-myocytes. PLoS One 2010; 5:e9689.
35. Makishima M, Lu TT, Xie W, et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002; 296:1313-1316.
36. Raufman JP, Zimniak P, Bartoszko-Malik A. Lithocholyltaurine interacts with cholinergic receptors on dispersed chief cells from guinea pig stomach. Am J Physiol 1998; 274:G997-G1004.
37. Raufman J-P, Chen Y, Cheng K, et al. Selective interaction of bile acids with muscarinic receptors: a case of molecular mimicry. Eur J Pharmacol 2002; 457:77-84.
38. Khurana S, Raufman JP, Pallone TL. Bile acids regulate cardiovascular function. Clin Transl Sci 2011; 4:210-218.
39. Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006; 439:484-489.
40. Swann JR, Want EJ, Geier FM, et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA 2011; 108 (Suppl 1):4523-4530.
41. Raufman J-P, Cheng K, Zimniak P. Activation of muscarinic receptor signaling by bile acids. Dig Dis Sci 2003; 48:1431-1444.